Goldman Sachs’s PetMed Express PETS Stock Holding History

Goldman Sachs’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-372,400	Closed	-$5.02M	–	7224
2014 Q2	$5.02M	Sell	372,400 -280,300	-43%	-$3.7M	﹤0.01%	3031
2014 Q1	$8.75M	Buy	+652,700	New	+$9.04M	﹤0.01%	2492

Other funds holding PETS

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SPH

Steel Partners Holdings New York $78M AUM

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Goldman Sachs's PETS Position: Q1 2026 in Review

Goldman Sachs sold out of PetMed Express (PETS) in Q1 2026, closing a stake of 24,713 shares — an estimated $79.1K sold.

Goldman Sachs first reported a position in PETS in Q2 2013 and held it in 49 quarters. The position peaked at $8.35M in Q3 2018. 49 funds tracked by Wall St. Rank hold PETS as of Q1 2026.

Goldman Sachs reported no remaining PetMed Express position as of Q1 2026 after selling out during the quarter.
Goldman Sachs sold 24,713 PetMed Express shares in Q1 2026, an estimated $79.1K.
Goldman Sachs first reported a position in PetMed Express in Q2 2013 and held it in 49 quarters.
Goldman Sachs's PetMed Express position peaked at $8.35M in Q3 2018.
49 funds tracked by Wall St. Rank held PetMed Express as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.